Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA - PubMed (original) (raw)
. 2005 Apr 7;48(7):2432-44.
doi: 10.1021/jm049606e.
Affiliations
- PMID: 15801834
- DOI: 10.1021/jm049606e
Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA
Junmei Wang et al. J Med Chem. 2005.
Abstract
In this work, an efficient strategy was presented to search drug leads for human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) using hierarchical database screenings, which included a pharmacophore model, multiple-conformation rigid docking, solvation docking, and molecular mechanics-Poisson-Boltzmann/surface area (MM-PB/SA) sequentially. Encouraging results were achieved in searching a refined available chemical directory (ACD) database: the enrichment factor after the first three filters was estimated to be 25-fold; the hit rate for all the four filters was predicted to be 41% in a control test using 37 known HIV-1 non-nucleoside reverse transcriptase inhibitors; 10 out of 30 promising solvation-docking hits had MM-PB/SA binding free energies better than -6.8 kcal/mol and the best one, HIT15, had -17.0 kcal/mol. In conclusion, the hierarchical multiple-filter database searching strategy is an attractive strategy in drug lead exploration.
Similar articles
- Docking of non-nucleoside inhibitors: neotripterifordin and its derivatives to HIV-1 reverse transcriptase.
Zhou Z, Madrid M, Madura JD. Zhou Z, et al. Proteins. 2002 Dec 1;49(4):529-42. doi: 10.1002/prot.10233. Proteins. 2002. PMID: 12402361 - A pharmacophore docking algorithm and its application to the cross-docking of 18 HIV-NNRTI's in their binding pockets.
Daeyaert F, de Jonge M, Heeres J, Koymans L, Lewi P, Vinkers MH, Janssen PA. Daeyaert F, et al. Proteins. 2004 Feb 15;54(3):526-33. doi: 10.1002/prot.10599. Proteins. 2004. PMID: 14748000 - Relative free energy of binding and binding mode calculations of HIV-1 RT inhibitors based on dock-MM-PB/GS.
Zhou Z, Madura JD. Zhou Z, et al. Proteins. 2004 Nov 15;57(3):493-503. doi: 10.1002/prot.20223. Proteins. 2004. PMID: 15382241 - Pyridin-2(1H)-ones: a promising class of HIV-1 non-nucleoside reverse transcriptase inhibitors.
Medina-Franco JL, Martínez-Mayorga K, Juárez-Gordiano C, Castillo R. Medina-Franco JL, et al. ChemMedChem. 2007 Aug;2(8):1141-7. doi: 10.1002/cmdc.200700054. ChemMedChem. 2007. PMID: 17477343 Review. No abstract available. - Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase.
Ren J, Stammers DK. Ren J, et al. Virus Res. 2008 Jun;134(1-2):157-70. doi: 10.1016/j.virusres.2007.12.018. Epub 2008 Mar 3. Virus Res. 2008. PMID: 18313784 Review.
Cited by
- The Advances and Limitations of the Determination and Applications of Water Structure in Molecular Engineering.
Zsidó BZ, Bayarsaikhan B, Börzsei R, Szél V, Mohos V, Hetényi C. Zsidó BZ, et al. Int J Mol Sci. 2023 Jul 22;24(14):11784. doi: 10.3390/ijms241411784. Int J Mol Sci. 2023. PMID: 37511543 Free PMC article. Review. - Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study.
Wang H, Wen J, Yang Y, Liu H, Wang S, Ding X, Zhou C, Zhang X. Wang H, et al. Front Pharmacol. 2022 Nov 18;13:1036208. doi: 10.3389/fphar.2022.1036208. eCollection 2022. Front Pharmacol. 2022. PMID: 36467060 Free PMC article. - Fast Identification of Possible Drug Treatment of Coronavirus Disease -19 (COVID-19) Through Computational Drug Repurposing Study.
Wang J. Wang J. ChemRxiv [Preprint]. 2020 Feb 21. doi: 10.26434/chemrxiv.11875446. ChemRxiv. 2020. PMID: 32510523 Free PMC article. Updated. Preprint. - Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study.
Wang J. Wang J. J Chem Inf Model. 2020 Jun 22;60(6):3277-3286. doi: 10.1021/acs.jcim.0c00179. Epub 2020 May 4. J Chem Inf Model. 2020. PMID: 32315171 Free PMC article. - Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim.
Su L, Wang Y, Wang J, Mifune Y, Morin MD, Jones BT, Moresco EMY, Boger DL, Beutler B, Zhang H. Su L, et al. J Med Chem. 2019 Mar 28;62(6):2938-2949. doi: 10.1021/acs.jmedchem.8b01583. Epub 2019 Mar 13. J Med Chem. 2019. PMID: 30829478 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical